FLAMAX 2ML №10 (AMPOULES)

Field of Activity:

Application:

Release form:

Composition:

Flamax International name: Ketoprofen Dosage form: Solution for intramuscular administration, 50 mg/ml   Compound: One ampoule contains: active substance – ketoprofen 100 mg Pharmacotherapeutic group: Nonstoroid anti-inflammatory drugs. Propionic acid derivatives. Ketoprofen. ATX code M01AE03   Pharmachologic effect: – analgesic – anti-inflammatory – antipyretic – antiplatelet   Indications for use: – inflammatory and degenerative diseases […]

Flamax



International name: Ketoprofen



Dosage form:

Solution for intramuscular administration, 50 mg/ml

 

Compound:

One ampoule contains:

active substance - ketoprofen 100 mg



Pharmacotherapeutic group:

Nonstoroid anti-inflammatory drugs.

Propionic acid derivatives. Ketoprofen.

ATX code M01AE03

 

Pharmachologic effect:

– analgesic

– anti-inflammatory

– antipyretic

– antiplatelet

 

Indications for use:

- inflammatory and degenerative diseases of the musculoskeletal

musculoskeletal system: rheumatoid, psoriatic,

juvenile chronic arthritis, ankylosing

spondylitis (Bechterew's disease), gouty arthritis,

rheumatic soft tissue disease, osteoarthritis

peripheral joints and spine

(including with radicular syndrome);
- lumbago, sciatica;

- neuralgia;

- migraine;

- algodismenorrhea;

- inflammatory processes of the pelvic organs,

incl. adnexitis;
- post-traumatic pain syndrome, accompanied by

inflammation;

- postoperative pain;

- toothache;

- pain syndrome in cancer.
Contraindications:

- erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase);

- bleeding from the gastrointestinal tract, inflammatory diseases

intestines in the acute phase (nonspecific ulcerative

colitis, Crohn's disease);
- severe renal failure (creatinine clearance <30 ml/min);

- progressive kidney diseases; hyperkalemia;

- complete or incomplete combination of bronchial asthma,

recurrent polyposis of the nose and paranasal sinuses and

intolerance to acetylsalicylic acid or other

NSAIDs (including in history);
- impaired hematopoiesis, impaired hemostasis

(including hemophilia);

- III trimester of pregnancy and lactation period;

- children under 15 years of age; period after

coronary artery bypass grafting;

- hypersensitivity (including to other NSAIDs or

auxiliary components).

 

Dosage regimen

Intramuscular administration:

100 mg (1 ampoule) 1-2 times a day.

Injections should be done deep intramuscularly.

The maximum daily dose should not exceed

200 mg Flamax.

The duration of treatment is determined by the doctor, not

It is recommended to continue treatment with the injection form

Flamax for more than 3 days.
[contact-form-7 id="327" title="Contact Us"]